Global Blood Irradiation Market (2021-2028) Analysis , Trends , Market report
A gamma irradiation chamber with a blood irradiator is a form of gamma irradiation chamber. The use of gamma rays to irradiate blood and blood products has been shown to reduce the incidence of post-transfusion graft versus host disease. The cellular blood components are irradiated before transfusion, according to the American Association of Blood Banks (AABB), to limit the development of viable T lymphocytes, which are the immediate cause of transfusion-associated graft versus host illness (TA-GVHD).
Self-contained dry source storage gamma irradiators are also known as gamma irradiation chambers (GIC), gamma chambers, blood irradiators (BI), or gamma cells, according to the Atomic Energy Regulation Board (AERB). In hospitals and blood banks, gamma irradiation chambers are used to irradiate blood and blood products/components, as well as for therapeutic and research purposes.
According to the study, gamma irradiation of cellular blood components is the best current
approach for reducing the risk of T-GVHD in recipients. As a result, it is
widely used as a lifesaving approach to this problem in hospitals and blood
banks all over the world. Blood is commonly irradiated with a cobalt-60 or
cesium-137 radioactive source in normal blood bags in specialized blood
irradiators.
During the
projected period, the blood irradiation market is expected to rise due to an
increase in the number of patients suffering from communicable and
non-communicable diseases, as well as technical improvements in the medical
device industry. Furthermore, improving health outcomes in medical devices is
expected to provide significant market growth possibilities.
Key Market
Drivers for Blood Irradiator
The global market for blood irradiation is divided into two categories: technology and end-user. Intravenous laser blood irradiation, transcutaneous laser blood
irradiation, and extracorporeal blood irradiation are the three techniques used
to classify the market. The market is divided into hospitals, blood banks,
diagnostic clinics, and research institutes based on the end-user.
The
"Global Blood Irradiation Market Analysis to 2028" is a professional
and in-depth analysis of the medical device industry, focusing on global market
trends. The report's goal is to give readers a broad overview of the global
market, as well as detailed market segmentation by technology, end-user, and
location. During the forecast period, the global market is expected to rise
rapidly.
The use of
X-ray irradiators have greatly reduced the risk. The use of X-ray irradiators
has improved the safety of our blood supply as well as the security of our
facilities. The use of an X-ray irradiator has also improved performance and
dependability. The market is driven by healthcare usage and acceptance.
Depending on
technology and end-user, the global blood irradiation market It also includes
market size and forecasts for the global market, as well as five major regions:
North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and
South and Central America, up to 2028. The blood irradiation market is further
split by nations and sectors within each region.
Product
launches, product approvals, and other organic growth tactics such as patents
and events are being prioritized by many companies. Acquisitions, as
well as partnerships and collaborations, were seen as inorganic growth tactics
in the market. These efforts have paved the road for market players to expand
their business and client base.
Market
Players :
- Typenex Medical, LLC
- UVLrx Therapeutics
- Hitachi Medical Systems
- Read Source Technologies
- Gilardoni S.p. A.

Comments
Post a Comment